These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22261783)

  • 1. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
    Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
    J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
    Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
    Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade.
    Ahn SJ; Choi SH; Kim YJ; Kim KG; Sohn CH; Han MH; Chang KH; Min HS
    Acad Radiol; 2012 Oct; 19(10):1233-40. PubMed ID: 22818788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
    Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
    PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Sugimura K
    AJR Am J Roentgenol; 2012 Jan; 198(1):75-82. PubMed ID: 22194481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram analysis of apparent diffusion coefficient maps in the prognosis of patients with locally advanced head and neck squamous cell carcinoma: Comparison of different region of interest selection methods.
    Ren JL; Yuan Y; Li XX; Shi YQ; Tao XF
    Eur J Radiol; 2018 Sep; 106():7-13. PubMed ID: 30150054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
    King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
    Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.
    Matoba M; Tuji H; Shimode Y; Toyoda I; Kuginuki Y; Miwa K; Tonami H
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):379-85. PubMed ID: 24029391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
    Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
    PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review.
    Chung SR; Choi YJ; Suh CH; Lee JH; Baek JH
    Korean J Radiol; 2019 Apr; 20(4):649-661. PubMed ID: 30887747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.
    de Perrot T; Lenoir V; Domingo Ayllón M; Dulguerov N; Pusztaszeri M; Becker M
    AJNR Am J Neuroradiol; 2017 Nov; 38(11):2153-2160. PubMed ID: 28912282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent diffusion coefficient for discriminating metastatic lymph nodes in patients with squamous cell carcinoma of the head and neck.
    Pekçevik Y; Çukurova İ; Arslan İB
    Diagn Interv Radiol; 2015; 21(5):397-402. PubMed ID: 26200481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
    Wong KH; Panek R; Dunlop A; Mcquaid D; Riddell A; Welsh LC; Murray I; Koh DM; Leach MO; Bhide SA; Nutting CM; Oyen WJ; Harrington KJ; Newbold KL
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):759-767. PubMed ID: 29164301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and
    Tsuchiya H; Matoba M; Nishino Y; Ota K; Doai M; Nagata H; Tuji H
    Radiat Oncol; 2023 Feb; 18(1):24. PubMed ID: 36747228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma.
    Noij DP; Pouwels PJW; Ljumanovic R; Knol DL; Doornaert P; de Bree R; Castelijns JA; de Graaf P
    Eur J Radiol; 2015 Jan; 84(1):108-116. PubMed ID: 25467228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.